Allergen, Individual-Tree pollen Acasia Babool (Acasia Longifolia) T19

The Allergen — Individual-Tree Pollen Acasia Babool (Acasia Longifolia) T19 is an at-home diagnostic test that measures allergen-specific IgE antibodies to Acasia Babool pollen in a patient’s blood. The assay identifies sensitization to this specific tree pollen (reported quantitatively in kUA/L and as a sensitization class), enabling targeted avoidance and clinical decision-making for allergy care in Dubai and across the UAE.

This test is useful for people experiencing seasonal rhinitis, conjunctivitis or asthma flares during local Acacia bloom, for individuals considering allergen immunotherapy, and for those with occupational or frequent outdoor exposure to Babool trees. A positive result indicates sensitization but must be correlated with clinical history; results are best reviewed with a clinician or allergist to design avoidance strategies, treatment plans or immunotherapy options tailored to the UAE environment.

• Allergen-specific IgE — Acasia Babool (Acasia Longifolia) pollen (kUA/L)
• Sensitization class / grade (0–6)
• Semi-quantitative presence/absence of specific IgE

• Recurrent seasonal sneezing, nasal congestion or itchy/watery eyes during Acacia bloom
• New or worsening asthma symptoms coinciding with outdoor pollen seasons
• After suspected pollen-triggered allergic reactions or repeated conjunctivitis
• Before initiating allergen-specific immunotherapy
• Frequent occupational or recreational exposure to Babool/Acacia trees in the UAE

• Identifies sensitization to Acasia Babool pollen for targeted management
• Supports personalized avoidance and environmental control strategies in Dubai/UAE
• Informs suitability and selection for allergen immunotherapy
• Convenient at-home sample collection with UAE-wide pickup options
• Clear quantitative results to guide clinician-led treatment and follow-up

• At-home blood collection (finger-prick kit) or phlebotomy by a trained technician on request
• No fasting required prior to sample collection
• Inform the laboratory/clinician if you are receiving allergen immunotherapy, biologic therapy, or had recent severe allergic reactions
• Suitable for adults and children; confirm testing for infants when booking